Normalization of the tumor vasculature through oncogenic inhibition: an emerging paradigm in tumor biology.
作者信息
Goel Shom, Fukumura Dai, Jain Rakesh K
出版信息
Proc Natl Acad Sci U S A. 2012 May 15;109(20):E1214. doi: 10.1073/pnas.1203794109. Epub 2012 May 1.
Abstract
摘要
相似文献
1
Normalization of the tumor vasculature through oncogenic inhibition: an emerging paradigm in tumor biology.通过致癌抑制实现肿瘤血管正常化：肿瘤生物学中的一个新兴范式。
Proc Natl Acad Sci U S A. 2012 May 15;109(20):E1214. doi: 10.1073/pnas.1203794109. Epub 2012 May 1.
2
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia.针对肿瘤细胞中的致癌丝氨酸/苏氨酸蛋白激酶 BRAF 可抑制血管生成并消除缺氧。
Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):E353-9. doi: 10.1073/pnas.1105026109. Epub 2011 Dec 27.
3
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.河马效应器YAP可促进对RAF和MEK靶向癌症疗法的抗性。
Nat Genet. 2015 Mar;47(3):250-6. doi: 10.1038/ng.3218. Epub 2015 Feb 9.
4
Role of Raf in vascular protection from distinct apoptotic stimuli.Raf在血管抵御不同凋亡刺激中的作用。
Science. 2003 Jul 4;301(5629):94-6. doi: 10.1126/science.1082015.
5
Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885.激酶抑制剂SB-590885对表达致癌性BRAF的肿瘤的遗传治疗指数的证明。
Cancer Res. 2006 Dec 1;66(23):11100-5. doi: 10.1158/0008-5472.CAN-06-2554.
6
YAP in MAPK pathway targeted therapy resistance.丝裂原活化蛋白激酶（MAPK）信号通路中Yes相关蛋白（YAP）与靶向治疗耐药性
Cell Cycle. 2015;14(12):1765-6. doi: 10.1080/15384101.2015.1032644.
7
[16th EORTC-NCI-AACR symposium on new molecular targets and cancer therapeutics].[第16届欧洲癌症研究与治疗组织-美国国立癌症研究所-美国癌症研究协会新型分子靶点与癌症治疗研讨会]
Bull Cancer. 2004 Dec;91(12):985-8.
8
Targeted therapies: Hippo effector YAP1 inhibition—towards a new therapeutic option to overcome drug resistance.靶向治疗：抑制Hippo效应因子YAP1——迈向克服耐药性的新治疗选择
Nat Rev Clin Oncol. 2015 Apr;12(4):190. doi: 10.1038/nrclinonc.2015.31. Epub 2015 Feb 24.
9
Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF.热休克蛋白27（HSP27，HSPB1）对于具有MET、EGFR和BRAF致癌激活的细胞具有合成致死性。
Mol Oncol. 2017 Jun;11(6):599-611. doi: 10.1002/1878-0261.12042. Epub 2017 May 8.
10
Targeting ALK, ROS1, and BRAF kinases.靶向间变性淋巴瘤激酶、原癌基因酪氨酸蛋白激酶1和B-Raf激酶。
J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S375-6. doi: 10.1097/JTO.0b013e31826df05e.
引用本文的文献
1
Synergistic mechanotherapy and sonopermeation guided by mathematical modeling for solid tumor treatment.基于数学建模指导的协同机械疗法和声透疗法用于实体瘤治疗
Front Drug Deliv. 2025 Jun 24;5:1549098. doi: 10.3389/fddev.2025.1549098. eCollection 2025.
2
Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer.谷胱甘肽过氧化物酶 2 通过氧化还原信号传导将血管调节与乳腺癌的代谢可塑性联系起来。
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8). doi: 10.1073/pnas.2107266119.
3
Payload Delivery: Engineering Immune Cells to Disrupt the Tumour Microenvironment.有效载荷递送：工程化免疫细胞以破坏肿瘤微环境
Cancers (Basel). 2021 Nov 29;13(23):6000. doi: 10.3390/cancers13236000.
4
Endothelial Regulation of Drug Transport in a 3D Vascularized Tumor Model.三维血管化肿瘤模型中药物转运的内皮调控
Adv Funct Mater. 2020 Nov 25;30(48). doi: 10.1002/adfm.202002444. Epub 2020 Jun 9.
5
Tumour angiogenesis normalized by myo-inositol trispyrophosphate alleviates hypoxia in the microenvironment and promotes antitumor immune response.肌醇三磷酸三异三聚体通过肿瘤血管正常化缓解微环境缺氧，促进抗肿瘤免疫反应。
J Cell Mol Med. 2021 Apr;25(7):3284-3299. doi: 10.1111/jcmm.16399. Epub 2021 Feb 23.
6
Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies.肿瘤缺氧调控免疫逃逸/浸润：对血管生成的影响及缺氧生物标志物对癌症治疗的潜在影响。
Front Immunol. 2021 Jan 20;11:613114. doi: 10.3389/fimmu.2020.613114. eCollection 2020.
7
Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies.缺氧介导的卵巢癌细胞对治疗反应的降低：对化疗和免疫治疗的意义。
Int J Mol Sci. 2020 Dec 14;21(24):9492. doi: 10.3390/ijms21249492.
8
Combining microenvironment normalization strategies to improve cancer immunotherapy.联合微环境正常化策略以提高癌症免疫治疗效果。
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3728-3737. doi: 10.1073/pnas.1919764117. Epub 2020 Feb 3.
9
6-Gingerol stabilized the p-VEGFR2/VE-cadherin/β-catenin/actin complex promotes microvessel normalization and suppresses tumor progression.6-姜酚稳定 p-VEGFR2/VE-钙黏蛋白/β-连环蛋白/肌动蛋白复合物，促进微血管正常化并抑制肿瘤进展。
J Exp Clin Cancer Res. 2019 Jul 2;38(1):285. doi: 10.1186/s13046-019-1291-z.
10
New Directions in the Study and Treatment of Metastatic Cancer.转移性癌症研究与治疗的新方向
Front Oncol. 2018 Jul 10;8:258. doi: 10.3389/fonc.2018.00258. eCollection 2018.
本文引用的文献
1
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia.针对肿瘤细胞中的致癌丝氨酸/苏氨酸蛋白激酶 BRAF 可抑制血管生成并消除缺氧。
Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):E353-9. doi: 10.1073/pnas.1105026109. Epub 2011 Dec 27.
2
Normalization of the vasculature for treatment of cancer and other diseases.血管正常化治疗癌症和其他疾病。
Physiol Rev. 2011 Jul;91(3):1071-121. doi: 10.1152/physrev.00038.2010.
3
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.肿瘤血管正常化：抗血管生成治疗中的一个新兴概念。
Science. 2005 Jan 7;307(5706):58-62. doi: 10.1126/science.1104819.
4
Tumour biology: herceptin acts as an anti-angiogenic cocktail.肿瘤生物学：赫赛汀起到抗血管生成混合物的作用。
Nature. 2002 Mar 21;416(6878):279-80. doi: 10.1038/416279b.
5
Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor.雄激素依赖性肿瘤去势后的内皮细胞死亡、血管生成及微血管功能：血管内皮生长因子的作用
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10820-5. doi: 10.1073/pnas.95.18.10820.
Zotero 插件